Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001128918.3(MARK3):āc.150A>Cā(p.Gln50His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000345 in 1,447,508 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
MARK3 (HGNC:6897): (microtubule affinity regulating kinase 3) The protein encoded by this gene is activated by phosphorylation and in turn is involved in the phosphorylation of tau proteins MAP2 and MAP4. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2011]
Gain of catalytic residue at A47 (P = 0.0072);Gain of catalytic residue at A47 (P = 0.0072);Gain of catalytic residue at A47 (P = 0.0072);Gain of catalytic residue at A47 (P = 0.0072);Gain of catalytic residue at A47 (P = 0.0072);Gain of catalytic residue at A47 (P = 0.0072);Gain of catalytic residue at A47 (P = 0.0072);Gain of catalytic residue at A47 (P = 0.0072);.;